Reprixys Pharmaceuticals Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$268M
Reprixys Pharmaceuticals General Information
Description
Operator of a biopharmaceutical company is focused on the development of therapeutics for the treatment of inflammation, thrombosis and metastasis across a broad range of severe diseases. The company develops an antibody directed against PSGL-1 for the treatment of Crohn's disease, multiple myeloma, and other inflammatory disorders, providing medical practitioners with a treatment for sickle cell disease.
Contact Information
Website
www.selexys.comCorporate Office
- 840 Research Parkway
- Suite 516
- Oklahoma City, OK 73104
- United States
Corporate Office
- 840 Research Parkway
- Suite 516
- Oklahoma City, OK 73104
- United States
Reprixys Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Merger/Acquisition | 18-Nov-2016 | $268M | Completed | Generating Revenue | ||
| 10. Later Stage VC (Series A) | 09-Feb-2015 | Completed | Clinical Trials - Phase 2 | |||
| 9. Grant | 01-Jan-2012 | Completed | Clinical Trials - Phase 2 | |||
| 8. Later Stage VC | 02-Nov-2011 | Completed | Clinical Trials - Phase 1 | |||
| 7. Grant | 01-Jan-2011 | Completed | Clinical Trials - Phase 1 | |||
| 6. Grant | 01-Jan-2010 | Completed | Clinical Trials - Phase 1 | |||
| 5. Later Stage VC | 18-Jun-2009 | Completed | Clinical Trials - Phase 1 | |||
| 4. Grant | 19-Feb-2009 | Completed | Clinical Trials - Phase 1 | |||
| 3. Early Stage VC | 15-Jun-2006 | Completed | Startup | |||
| 2. Grant | $12M | Completed | Startup |
Reprixys Pharmaceuticals Comparisons
Industry
Financing
Details
Reprixys Pharmaceuticals Competitors (59)
One of Reprixys Pharmaceuticals’s 59 competitors is Phathom Pharmaceuticals, a Formerly VC-backed company based in Florham Park, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Phathom Pharmaceuticals | Formerly VC-backed | Florham Park, NJ | ||||
| Annexon Biosciences | Formerly VC-backed | Brisbane, CA | ||||
| Sarepta Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Idorsia Pharmaceuticals | Corporation | Allschwil, Switzerland | ||||
| uniQure | Formerly VC-backed | Amsterdam, Netherlands |
Reprixys Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Reprixys Pharmaceuticals Patents
Reprixys Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2011349124-A1 | Anti-p-selectin antibodies and methods of their use and identification | Active | 21-Dec-2010 | ||
| AU-2011349124-B2 | Anti-p-selectin antibodies and methods of their use and identification | Active | 21-Dec-2010 | ||
| AU-2016262660-A1 | Anti-p-selectin antibodies and methods of their use and identification | Inactive | 21-Dec-2010 | ||
| EP-3222635-A1 | Anti-p-selectin antibodies and methods of their use and identification | Inactive | 21-Dec-2010 | ||
| JP-2017048215-A | Anti-p-selectin antibodies and methods of their use and identification | Active | 21-Dec-2010 | C07K16/2854 |
Reprixys Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Reprixys Pharmaceuticals Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MPM BioImpact | Venture Capital | Minority | ||
| Oklahoma Life Science Fund | Venture Capital | Minority | ||
| SeedStep Angels | Angel Group | Minority | ||
| U.S. Department of Health and Human Services | Government | |||
| i2E | Accelerator/Incubator | Minority |
Reprixys Pharmaceuticals FAQs
-
When was Reprixys Pharmaceuticals founded?
Reprixys Pharmaceuticals was founded in 2002.
-
Where is Reprixys Pharmaceuticals headquartered?
Reprixys Pharmaceuticals is headquartered in Oklahoma City, OK.
-
What is the size of Reprixys Pharmaceuticals?
Reprixys Pharmaceuticals has 7 total employees.
-
What industry is Reprixys Pharmaceuticals in?
Reprixys Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Reprixys Pharmaceuticals a private or public company?
Reprixys Pharmaceuticals is a Private company.
-
What is the current valuation of Reprixys Pharmaceuticals?
The current valuation of Reprixys Pharmaceuticals is .
-
What is Reprixys Pharmaceuticals’s current revenue?
The current revenue for Reprixys Pharmaceuticals is .
-
How much funding has Reprixys Pharmaceuticals raised over time?
Reprixys Pharmaceuticals has raised $52.1M.
-
Who are Reprixys Pharmaceuticals’s investors?
MPM BioImpact, Oklahoma Life Science Fund, SeedStep Angels, U.S. Department of Health and Human Services, and i2E have invested in Reprixys Pharmaceuticals.
-
Who are Reprixys Pharmaceuticals’s competitors?
Phathom Pharmaceuticals, Annexon Biosciences, Sarepta Therapeutics, Idorsia Pharmaceuticals, and uniQure are some of the 59 competitors of Reprixys Pharmaceuticals.
-
When was Reprixys Pharmaceuticals acquired?
Reprixys Pharmaceuticals was acquired on 18-Nov-2016.
-
Who acquired Reprixys Pharmaceuticals?
Reprixys Pharmaceuticals was acquired by Novartis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
